Claims
- 1. A water soluble compound formed by complexing branched beta cyclodextrin with a steroid having a molecular structure that can fit into the cavity of the branched beta cyclodextrin and form a complex with the branched beta cyclodextrin.
- 2. The water soluble compound of claim 1 wherein the steroid is selected from the group consisting of: corticosteroids, androgens, anabolic steroids, estrogens, and progestogens; that have a molecular structure that can fit into the cavity of the branched beta cyclodextrin and form a complex with the branched beta cyclodextrin.
- 3. The water soluble compound of claim 1 wherein the steroid is selected from the group consisting of: dexamethasone, prednisolone and cholesterol.
- 4. The water soluble compound of claim 1 wherein the branched beta cyclodextrin has a branch containing between about 1 glucose unit to about 7 glucose units.
- 5. The water soluble compound of claim 3 wherein the branched beta cyclodextrin has a branch containing between about 1 glucose unit to about 7 glucose units.
- 6. A method for increasing the solubility of a steroid comprising the steps of:
- (a) forming an aqueous mixture of branched beta cyclodextrin and steroid in a stoichiometric ratio of about 1:1; and
- (b) recovering a complex of branched beta cyclodextrin and steroid.
- 7. The method of claim 6 wherein the formation of the aqueous mixture of branched beta cyclodextrin and steroid is conducted under ambient conditions.
- 8. The method of claim 6 wherein the formation step is accomplished by adding branched beta cyclodextrin to water and then adding the steroid and mixing the branched beta cyclodextrin and steroid in water for a period of about 4 to about 24 hours under ambient conditions.
- 9. The method of claim 6 wherein the recovery step is accomplished by evaporation.
- 10. The method of claim 8 wherein the recovery step is accomplished by evaporation.
Parent Case Info
This is a continuation of application Ser. No. 920,010 filed Jul. 27, 1992, now U.S. Pat. No. 5,229,370 which in turn is a continuation of application Ser. No. 711,108 filed Jun. 18, 1991, now abandoned, which in turn was a continuation of application Ser. No. 232,440 filed Aug. 15, 1988, now abandoned.
US Referenced Citations (8)
Foreign Referenced Citations (9)
Number |
Date |
Country |
327766 |
Aug 1989 |
EPX |
0220226 |
Mar 1985 |
DEX |
62-123196 |
Jun 1987 |
JPX |
62-164701 |
Jul 1987 |
JPX |
62-281855 |
Dec 1987 |
JPX |
63-27440 |
Feb 1988 |
JPX |
63-135402 |
Jun 1988 |
JPX |
2109381 |
Jun 1983 |
GBX |
8502767 |
Jul 1985 |
WOX |
Non-Patent Literature Citations (9)
Entry |
Szetli; Akademiai Klado, Budapest, 1982, pp. 204-235: "Cyclodextrins and Drugs". |
Uekama et al.; International Journal of Pharmaceutics 10: 1-15 (1982). |
Lopata et al.; QSAR Strat. Des. Bioact. Compd. Proc. Er. Symp. Quant. 5-A Relat pp. 353-356 (1985). |
Starch/Starke 38 (1986) Nr. 11-J. SzejtliI-pp. 388-390 "Cyclodextrins in Biotechnology". |
Koizumi et al.; Carbohydrate Research 153: 55-67 (1986). |
Koizumi et al.; Chemical and Pharmaceutical Bulletin 35 (8): 3413-3418 (Aug. 1987). |
Koizumi et al.; Chemical Abstracts 110: 121385c (1989). |
Yamamoto et al.; International Journal of Pharmaceutics 49: 163-171 (1989). |
Taylor et al.; Pharmaceutical Research 6(7): 641-646 (1989). |
Continuations (3)
|
Number |
Date |
Country |
Parent |
920010 |
Jul 1992 |
|
Parent |
711108 |
Jun 1991 |
|
Parent |
232440 |
Aug 1988 |
|